Seminars in Nephrology
Volume 29, Issue 1 , Pages 15-23 , January 2009

Why Are Chronic Kidney Disease Patients Anorexic and What Can Be Done About It?

  • Charles Chazot, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Charles Chazot, MD, Centre de Rein Artificiel, 42 avenue du 8 Mai 1945, 69160 Tassin, France

References 

  1. Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM. Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol. 1995;6:1386–1391
  2. Burrowes JD, Larive B, Chertow GM, Cockram DB, Dwyer JT, Greene T, et al. Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the Hemodialysis (HEMO) Study. Nephrol Dial Transplant. 2005;20:2765–2774Available from: www.ingentaconnect.com
  3. Carrero JJ, Qureshi AR, Axelsson J, Avesani CM, Suliman ME, Kato S, et al. Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr. 2007;85:695–701
  4. Kalantar-Zadeh K. Causes and consequences of the reverse epidemiology of body mass index in dialysis patients. J Ren Nutr. 2005;15:142–147
  5. Lopes AA, Elder SJ, Ginsberg N, Andreucci VE, Cruz JM, Fukuhara S, et al. Lack of appetite in haemodialysis patients—associations with patient characteristics, indicators of nutritional status and outcomes in the international DOPPS. Nephrol Dial Transplant. 2007;22:3538–3546
  6. Sutton D, Higgins B, Stevens JM. Continuous ambulatory peritoneal dialysis patients are unable to increase dietary intake to recommended levels. J Ren Nutr. 2007;17:329–335
  7. Mehrotra R, Kopple JD. Protein and energy nutrition among adult patients treated with chronic peritoneal dialysis. Adv Ren Replace Ther. 2003;10:194–212
  8. Aguilera A, Codoceo R, Bajo MA, Iglesias P, Diez JJ, Barril G, et al. Eating behavior disorders in uremia: a question of balance in appetite regulation. Semin Dial. 2004;17:44–52
  9. Aguilera A, Sanchez-Tomero JA, Selgas R. Brain activation in uremic anorexia. J Ren Nutr. 2007;17:57–61
  10. Korner J, Leibel RL. To eat or not to eat—how the gut talks to the brain. N Engl J Med. 2003;349:926–928
  11. Nardone G, Rocco A, Fiorillo M, Del Pezzo M, Autiero G, Cuomo R, et al. Gastroduodenal lesions and Helicobacter pylori infection in dyspeptic patients with and without chronic renal failure. Helicobacter. 2005;10:53–58
  12. De Schoenmakere G, Vanholder R, Rottey S, Duym P, Lameire N. Relationship between gastric emptying and clinical and biochemical factors in chronic haemodialysis patients. Nephrol Dial Transplant. 2001;16:1850–1855
  13. Fernstrom A, Hylander B, Gryback P, Jacobsson H, Hellstrom PM. Gastric emptying and electrogastrography in patients on CAPD. Perit Dial Int. 1999;19:429–437
  14. Simenhoff ML, Dunn SR, Zollner GP, Fitzpatrick ME, Emery SM, Sandine WE, et al. Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus. Miner Electrolyte Metab. 1996;22:92–96
  15. Anderstam B, Mamoun AH, Sodersten P, Bergstrom J. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. J Am Soc Nephrol. 1996;7:2453–2460
  16. Kopple JD, Greene T, Chumlea WC, Hollinger D, Maroni BJ, Merrill D, et al. Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int. 2000;57:1688–1703
  17. Chazot C, Charra B, Vo Van C, Jean G, Vanel T, Calemard E, et al. The Janus-faced aspect of ‘dry weight.’. Nephrol Dial Transplant. 1999;14:121–124
  18. Mehrotra R, Berman N, Alistwani A, Kopple JD. Improvement of nutritional status after initiation of maintenance hemodialysis. Am J Kidney Dis. 2002;40:133–142
  19. Burrowes JD, Larive B, Cockram DB, Dwyer J, Kusek JW, McLeroy S, et al. Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis treatment days in hemodialysis patients: cross-sectional results from the HEMO study. J Ren Nutr. 2003;13:191–198
  20. Chauveau P, Grigaut E, Kolko A, Wolff P, Combe C, Aparicio M. Evaluation of nutritional status in patients with kidney disease: usefulness of dietary recall. J Ren Nutr. 2007;17:88–92
  21. Galland R, Traeger J, Arkouche W, Delawari E, Fouque D. Short daily hemodialysis and nutritional status. Am J Kidney Dis. 2001;37:S95–S98
  22. Chauveau P, Naret C, Puget J, Zins B, Poignet JL. Adequacy of haemodialysis and nutrition in maintenance haemodialysis patients: clinical evaluation of a new on-line urea monitor. Nephrol Dial Transplant. 1996;11:1568–1573
  23. Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial. 2002;15:329–337
  24. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr. 2004;80:299–307
  25. Espat NJ, Copeland EM, Moldawer LL. Tumor necrosis factor and cachexia: a current perspective. Surg Oncol. 1994;3:255–262
  26. McCarthy DO. Tumor necrosis factor alpha and interleukin-6 have differential effects on food intake and gastric emptying in fasted rats. Res Nurs Health. 2000;23:222–228
  27. Avesani CM, Carrero JJ, Axelsson J, Qureshi AR, Lindholm B, Stenvinkel P. Inflammation and wasting in chronic kidney disease: partners in crime. Kidney Int. 2006;70:S8–S13
  28. Siassi F, Wang M, Kopple JD, Swendseid ME. Brain serotonin turnover in chronically uremic rats. Am J Physiol. 1977;232:E526–E528
  29. Bergstrom J, Alvestrand A, Furst P. Plasma and muscle free amino acids in maintenance hemodialysis patients without protein malnutrition. Kidney Int. 1990;38:108–114
  30. Kopple JD, Swendseid ME. Protein and amino acid metabolism in uremic patients undergoing maintenance hemodialysis. Kidney Int Suppl. 1975;7:64–72
  31. Sharma K, Considine RV, Michael B, Dunn SR, Weisberg LS, Kurnik BR, et al. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int. 1997;51:1980–1985
  32. Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak RH. Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest. 2005;115:1659–1665
  33. Marks DL, Cone RD. Central melanocortins and the regulation of weight during acute and chronic disease. Recent Prog Horm Res. 2001;56:359–375
  34. Aguilera A, Cirugeda A, Amair R, Sansone G, Alegre L, Codoceo R, et al. Ghrelin plasma levels and appetite in peritoneal dialysis patients. Adv Perit Dial. 2004;20:194–199
  35. Iglesias P, Diez JJ, Fernandez-Reyes MJ, Codoceo R, Alvarez-Fidalgo P, Bajo MA, et al. Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis. Clin Endocrinol (Oxf). 2006;64:68–73
  36. Yoshimoto A, Mori K, Sugawara A, Mukoyama M, Yahata K, Suganami T, et al. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol. 2002;13:2748–2752
  37. Odar-Cederlof I, Ericsson F, Theodorsson E, Kjellstrand CM. Is neuropeptide Y a contributor to volume-induced hypertension?. Am J Kidney Dis. 1998;31:803–808
  38. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Parlongo S, Cutrupi S, et al. Prospective study of neuropeptide Y as an adverse cardiovascular risk factor in end-stage renal disease. J Am Soc Nephrol. 2003;14:2611–2617
  39. Wright M, Woodrow G, O'Brien S, King N, Dye L, Blundell J, et al. Disturbed appetite patterns and nutrient intake in peritoneal dialysis patients. Perit Dial Int. 2003;23:550–556
  40. Canaud B, Bouloux C, Rivory JP, Taib J, Garred LJ, Florence P, et al. Erythropoietin-induced changes in protein nutrition: quantitative assessment by urea kinetic modeling analysis. Blood Purif. 1990;8:301–308
  41. Kokot F, Wiecek A, Mesjasz J, Adamczak M, Spiechowicz U. Influence of long-term recombinant human erythropoietin (rHuEpo) therapy on plasma leptin and neuropeptide Y concentration in haemodialysed uraemic patients. Nephrol Dial Transplant. 1998;13:1200–1205
  42. Fouque D, Vennegoor M, ter Wee P, Wanner C, Basci A, Canaud B, et al. EBPG guideline on nutrition. Nephrol Dial Transplant. 2007;22:ii45–ii87
  43. Leon JB, Albert JM, Gilchrist G, Kushner I, Lerner E, Mach S, et al. Improving albumin levels among hemodialysis patients: a community-based randomized controlled trial. Am J Kidney Dis. 2006;48:28–36
  44. Johansen KL. Exercise in the end-stage renal disease population. J Am Soc Nephrol. 2007;18:1845–1854Available from: www.jasn.asnjournals.org
  45. Frey S, Mir AR, Lucas M. Visceral protein status and caloric intake in exercising versus nonexercising individuals with end-stage renal disease. J Ren Nutr. 1999;9:71–77
  46. Kopple JD, Wang H, Casaburi R, Fournier M, Lewis MI, Taylor W, et al. Exercise in maintenance hemodialysis patients induces transcriptional changes in genes favoring anabolic muscle. J Am Soc Nephrol. 2007;18:2975–2986Available from: www.jasn.asnjournals.org
  47. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis. 2000;35:S1–S140
  48. Rocco MV, Dwyer JT, Larive B, Greene T, Cockram DB, Chumlea WC, et al. The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: results of the HEMO Study. Kidney Int. 2004;65:2321–2334
  49. Chazot C, Vo VC, Blanc C, Hurot JM, Jean G, Vanel T, et al. Stability of nutritional parameters during a 5-year follow-up in patients treated with sequential long-hour hemodialysis. Hemodial Int. 2006;10:389–393
  50. Galland R, Traeger J, Arkouche W, Cleaud C, Delawari E, Fouque D. Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int. 2001;60:1555–1560
  51. Alloatti S, Molino A, Manes M, Bonfant G, Pellu V. Long nocturnal dialysis. Blood Purif. 2002;20:525–530
  52. Charra B, Laurent G, Chazot C, Jean G, Terrat JC, Vanel T. Hemodialysis trends in time, 1989 to 1998, independent of dose and outcome. Am J Kidney Dis. 1998;32:S63–S70
  53. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters (The Italian Cooperative Dialysis Study Group). Kidney Int. 1996;50:1293–1302
  54. Savica V, Ciolino F, Monardo P, Mallamace A, Savica R, Santoro D, et al. Nutritional status in hemodialysis patients: options for on-line convective treatment. J Ren Nutr. 2006;16:237–240
  55. Schiffl H. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. Eur J Med Res. 2007;12:26–33
  56. Wizemann V, Lotz C, Techert F, Uthoff S. On-line haemodiafiltration versus low-flux haemodialysis (A prospective randomized study). Nephrol Dial Transplant. 2000;15:43–48
  57. Davies SJ, Phillips L, Griffiths AM, Naish PF, Russell GI. Analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients. Kidney Int. 2000;57:1743–1754
  58. Maltoni M, Nanni O, Scarpi E, Rossi D, Serra P, Amadori D. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Ann Oncol. 2001;12:289–300
  59. Yeh SS, Wu SY, Levine DM, Parker TS, Olson JS, Stevens MR, et al. The correlation of cytokine levels with body weight after megestrol acetate treatment in geriatric patients. J Gerontol A Biol Sci Med Sci. 2001;56:M48–M54
  60. Batterham MJ, Garsia R. A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss. Int J Androl. 2001;24:232–240
  61. Von Roenn JH, Armstrong D, Kotler DP, Cohn DL, Klimas NG, Tchekmedyian NS, et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med. 1994;121:393–399
  62. Wermers RA, Hurley DL, Kearns AE. Osteoporosis associated with megestrol acetate. Mayo Clin Proc. 2004;79:1557–1571
  63. Mantovani G, Maccio A, Lai P, Massa E, Ghiani M, Santona MC. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Semin Oncol. 1998;25:45–52
  64. Williams JL, Perius M, Humble L, Sigler D, Urbanes A, Shapiro HS. Effect of megestrol acetate on the nutritional status of malnourished hemodialysis patients. [abstract] J Ren Nutr. 1997;7:231
  65. Boccanfuso JA, Hutton M, McAllister B. The effects of megestrol acetate on nutritional parameters in a dialysis population. J Ren Nutr. 2000;10:36–43
  66. Costero O, Bajo MA, del Peso G, Gil F, Aguilera A, Ros S, et al. Treatment of anorexia and malnutrition in peritoneal dialysis patients with megestrol acetate. Adv Perit Dial. 2004;20:209–212
  67. Lien YH, Ruffenach SJ. Low dose megestrol increases serum albumin in malnourished dialysis patients. Int J Artif Organs. 1996;19:147–150
  68. Burrowes JD, Bluestone PA, Wang J, Pierson RN. The effects of moderate doses of megestrol acetate on nutritional status and body composition in a hemodialysis patient. J Ren Nutr. 1999;9:89–94
  69. Rammohan M, Kalantar-Zadeh K, Liang A, Ghossein C. Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients. J Ren Nutr. 2005;15:345–355
  70. Hiroshige K, Sonta T, Suda T, Kanegae K, Ohtani A. Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis. Nephrol Dial Transplant. 2001;16:1856–1862
  71. Cano N, Labastie-Coeyrehourq J, Lacombe P, Stroumza P, di Costanzo-Dufetel J, Durbec JP, et al. Predialytic parenteral nutrition with lipids and amino acids in malnourished hemodialysis patients. Am J Clin Nutr. 1990;52:726–730

PII: S0270-9295(08)00166-6

doi: 10.1016/j.semnephrol.2008.10.003

Seminars in Nephrology
Volume 29, Issue 1 , Pages 15-23 , January 2009

Article Tools

* Image Usage & Resolution